Regeneron skids on shortfall in Eylea sales By: MarketWatch November 04, 2014 at 11:15 AM EST A shortfall in sales of Regeneron’s Eylea eye drug takes a bite out of the company’s third-quarter results Read More >> Related Stocks: Regeneron Pharmaceuticals